Clinical Trials Directory

Trials / Unknown

UnknownNCT00173823

Malnutrition and Inflammation in Dialysis Patients in Taiwan

Malnutrition and Inflammation in Taiwan: Prospective Outcome Evaluation Method (MIT-POEM) in Dialysis Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
1,500 (planned)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

According to the reports of the United States Renal Data System (USRDS), there is a 25% annual mortality rate with nearly 50% of all reported maintenance hemodialysis (HD) patient deaths attributed to atherosclerosis-related complications. Although traditional risk factors of cardiovascular disease (CVD) are common in end-stage renal disease (ESRD) patients, they alone may be insufficient to account for their high prevalence of CVD. Recent evidence demonstrated high plasma homocysteine levels have been established as a risk factor of chronic inflammation and atherosclerosis in patients with ESRD. Malnutrition and inflammation was associated with poor quality of life, morbidity and mortality. We, the researchers at National Taiwan University Hospital, hope to establish the best predictive profile of HD patient outcome. Thus, we establish several protocols to complete this work.

Conditions

Timeline

Start date
2004-06-01
First posted
2005-09-15
Last updated
2006-03-13

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT00173823. Inclusion in this directory is not an endorsement.

Malnutrition and Inflammation in Dialysis Patients in Taiwan (NCT00173823) · Clinical Trials Directory